ARTICLE | Clinical News
Matrix reports Phase II data
October 12, 2000 7:00 AM UTC
In a Phase II study of 31 patients with unresectable liver metastases from colorectal cancer, MATX said that 9 patients responded to therapy with its IntraDose injectable gel containing cisplatin and ...